Efficacy and Tolerability of Fesoterodine in Subjects Stratified by Dose Escalation in an Open-Label Flexible-Dose Study

Morrow J D1, Goldfischer E R2, Gong J1, Tseng L1, Guan Z1, Wyndaele J J3

Abstract Category

Pharmacology: Clinical

Abstract 712
Read by Title
Scientific Non Discussion Abstract Session 34
1. Pfizer Inc, New York, NY, USA, 2. Hudson Valley Urology, P.C., Poughkeepsie, NY, USA, 3. Department of Urology, Universiteit en Universitair Ziekenhuis Antwerpen, Antwerp, Belgium